Literature DB >> 3394587

The clinical significance of elevated CSF and plasma histamine in cerebral aneurysm surgery utilizing cardiopulmonary bypass with total circulatory arrest.

A Marath1, P Richards, W Man, K M Taylor, C Lincoln, N Soni, J M Rice-Edwards, A Bartoli, D Gladstone.   

Abstract

Recently there has been a renewed interest in the neurosurgical treatment of large cerebral aneurysms and AV malformations utilising cardiopulmonary bypass (CPB) and total circulatory arrest (TCA). However, the differing tolerance limits of coagulation and bleeding, pH control and fluid constraint are difficult to reconcile. Although clinical assessment, electro encephalogram (EEG) and intracranial pressure-monitoring assist in identification of cerebral damage, CPB and TCA inflict their own penalties with resultant uncertainty in post-operative neurological evaluation, and producing difficulties in interpretation and management. Additionally, an unanswered question is, to what extent the known cardiac and cerebral effects of circulating histamine might influence the post-circulatory arrest recovery in these patients, and whether this would further compromise the neurological result. We report our experience of 9 such cases who underwent this procedure, and were able to achieve a satisfactory neurological result in 7 patients with differing lesions. During the operation both CSF (from the open cranium) and blood (from the right internal jugular vein) were sampled at intervals for subsequent plasma histamine estimation. Despite markedly elevated histamine levels during CPB and TCA, this was not associated with an unfavourable neurological outcome. These early findings have given us encouragement to the useful role of CPB and TCA in these complex neurosurgical presentations, and raise interesting questions about the clinical importance of histamine-evoked cerebral ischaemia that has been demonstrated in experimental models.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394587     DOI: 10.1007/bf02142583

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

1.  Histamine release in paediatric cardiopulmonary bypass--a possible role in the capillary leak syndrome.

Authors:  A Marath; W Man; K M Taylor
Journal:  Agents Actions       Date:  1987-04

Review 2.  H1 and H2 blockade: a prophylactic principle in anaesthesia and surgery against histamine-release responses of any degree of severity: Part II.

Authors:  W Lorenz; A Doenicke
Journal:  N Engl Reg Allergy Proc       Date:  1985

3.  [The liberation of histamine and serotonin during extracorporeal circulation].

Authors:  C Meyer-Burgdorff; G Seidel; F J Schlüter
Journal:  Anaesthesist       Date:  1973-05       Impact factor: 1.041

4.  Management of difficult intracranial aneurysms by deep hypothermia and elective cardiac arrest using cardiopulmonary bypass.

Authors:  P G Richards; A Marath; J M Edwards; C Lincoln
Journal:  Br J Neurosurg       Date:  1987       Impact factor: 1.596

5.  Experimental cerebral infarction in primates: regional changes in brain histamine content.

Authors:  N Subramanian; D Theodore; J Abraham
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

6.  Inotropic effects of histamine in human myocardium: differentiation between positive and negative components.

Authors:  Z G Guo; R Levi; L M Graver; D A Robertson; W A Gay
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

7.  Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker.

Authors:  T Watanabe; Y Taguchi; S Shiosaka; J Tanaka; H Kubota; Y Terano; M Tohyama; H Wada
Journal:  Brain Res       Date:  1984-03-12       Impact factor: 3.252

8.  Effect of pentagastrin on histamine output from the stomach in patients with duodenal ulcer.

Authors:  W K Man; J H Saunders; C Ingoldby; J Spencer
Journal:  Gut       Date:  1981-11       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.